KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 89 filers reported holding KALA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 5.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $14,000 | +600.0% | 12,300 | +1464.9% | 0.00% | – |
| Q3 2021 | $2,000 | -93.1% | 786 | -86.1% | 0.00% | -100.0% |
| Q2 2021 | $29,000 | +81.2% | 5,659 | +128.0% | 0.00% | 0.0% |
| Q4 2020 | $16,000 | +220.0% | 2,482 | +255.1% | 0.00% | +100.0% |
| Q3 2020 | $5,000 | -89.1% | 699 | -84.2% | 0.00% | -83.3% |
| Q2 2020 | $46,000 | – | 4,426 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |